|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 24 studies with search of: | Open Studies | "Acromegaly" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Unknown † |
Lanreotide Levels in Acromegaly
|
||||
| 2 | Recruiting |
The Treatment and Natural History of Acromegaly
|
||||
| 3 | Recruiting |
Ultrasound Guided Sandostatin LAR Injection in Acromegaly
|
||||
| 4 | Recruiting |
Efficacy and Safety of Octreolin for Acromegaly
|
||||
| 5 | Recruiting |
Study of Heart Effects When Growth Hormone (GH) is Used for Growth Hormone Deficiency (GHD) Following Cure of Acromegaly
|
||||
| 6 | Recruiting |
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
|
||||
| 7 | Recruiting |
Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
|
||||
| 8 | Recruiting |
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
|
||||
| 9 | Recruiting |
A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
|
||||
| 10 | Recruiting |
Effects of Sandostatin LAR® in Acromegaly
|
||||
| 11 | Recruiting |
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
|
||||
| 12 | Recruiting |
Acromegaly Combination Treatment Study
|
||||
| 13 | Unknown † |
Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
|
||||
| 14 | Unknown † |
Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT)
|
||||
| 15 | Recruiting |
Tissue Biomarker for Pegvisomant Action
|
||||
| 16 | Recruiting |
The Observational Study of Growth Hormone-secreting Pituitary Tumors
|
||||
| 17 | Unknown † |
Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States
|
||||
| 18 | Recruiting |
Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs
|
||||
| 19 | Unknown † |
Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas
|
||||
| 20 | Recruiting |
Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-24) |
|